The Dish’s Weekly Biotechnology News Wrap Up – January 29, 2016
This week’s biotechnology news headlines include, Zika virus, human microbiome collaboration, FDA expands use of Opdivo, Yervoy combo, FDA gives full approval to Amgen blood cancer drug, biosimilar naming with FDA petition, and work to combat drug resistant superbugs.
Cell Culture Events
Conferences:
February
Cell Therapy Manufacturing – February 3-4, 2016– Brussels, Belgium
http://www.informa-ls.com/event/celltherapy15
Cell Culture World Congress – February 23-24, 2016 –Munich Germany
The Cell Culture World Congress is where pharma, biotechs, researchers & innovative start-ups gather to develop new strategies and partnerships to advance biotherapeutic production, manufacture, and commercialisation. Join the largest cell culture event focused on producing new therapeutics and immunotherapies at a commercial scale and see where biologic manufacture is headed next.
Key speakers include:
Dr Stefan Wildt, VP, Global Head Technical Research and Development, Cell- and Gene Therapies, Novartis.
Bo Kara, Head Process Development, Advanced Therapy Delivery, GSK
Sam Wadsworth, CSO, Dimension Therapeutics
Dr Lorenz Mayr Vice President of Reagents & Assay Development at AstraZeneca
For more information download the brochure: http://bit.ly/1JJWO5y
Downstream Processing World Congress – February 23-24, 2016 – Munich Germany
The Downstream Processing World Congress 2016 will introduce new and exciting content focusing on innovation and development with an emphasis on new methods. Showcasing exciting new technologies such as purifying complex molecules, PAT, continuous purification, chromatography alternatives and new methods of purification. Content will include cutting edge research and even more case studies , over 40 presentations from those working in bioprocess in big pharma, interactive sessions with biotechs and will be collocated with the 6th annual Cell Culture World Congress.
Key speakers include:
Dr Mark Federspiel, Director, Viral Vector Production Laboratory, Department of Molecular Medicine, Mayo Clinic
Dr Yogesh Waghmare, Staff Scientist, Late Stage Process Development, Genzyme Sanofi
Nicholas Clarkson, Group Lead, Analytical Development, Oxford Biomedica
Prof Manuel Carrondo, Director, IBET
For more information download the brochure: http://bit.ly/1l5kQMx
March
ISBioTech 6th Spring Meeting – March 7-9, 2016 -Washington, DC
www.isbiotech.org/6thspringmeeting
Three concurrent programs on:
– Cellular Therapies
– Viral Vectors & Vaccines
– Baculovirus Expression Technology
BPI West – March 14-March 17, 2015 – Oakland Marriott City Center, Oakland, CA
http://www.ibclifesciences.com/BDPWeek/overview.xml
World Vaccine Congress – March 29-30, 2016 –Grand Hyatt– Washington D.C.
http://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm
Check out the Top Blogs, Top Ask the Expert Sessions and Top Cool Tool Features of 2015 –
The Top 25 Cell Culture Dish Blogs in 2015
The Top 10 Ask the Expert Sessions in 2015
The Top 10 Cell Culture Dish Cool Tools Features in 2015
Headlines
“Glaxo evaluating possibility of using vaccine technology for Zika,” Reuters
“GlaxoSmithKline Plc is concluding feasibility studies evaluating whether its vaccine technology is suitable for the Zika virus, which has been linked to brain damage in thousands of babies in Brazil, a spokeswoman told Reuters.”
If you like this story, please see our blog titled “Biomanufacturing CHO Media – A look at different approaches and optimization opportunities”
“Ferring, Karolinska Institutet Launch Human Microbiome Collaboration,” Genetic Engineering News
“Ferring Pharmaceuticals said today it will partner with the Karolinska Institutet to establish a research center that will carry out translational research on the human microbiome.”
If you like this story, please see our blog titled “Cool Tool – Gibco Essential 8 Flex Stem Cell Media Eliminates Need for Daily Feeding”
“FDA expands use of BMS’ Opdivo, Yervoy combo,” PharmaTimes
“Bristol-Myers Squibb’s Opdivo has won accelerated approval in the US in combination with Yervoy as a treatment for patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma.”
If you like this story, please see our blog titled “Biomanufacturing Innovations are Plentiful at This Year’s BPI Conference”
“FDA gives full approval to Amgen blood cancer drug,” Reuters
“The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc’s cancer drug Kyprolis in combination with certain other therapies to treat patients with multiple myeloma.”
If you like this story, please see our blog titled “Cool Tool- Hybridoma cell growth and performance in reduced serum + Zap-SR”
“PhRMA, BIO Double Down on Biosimilar Naming With FDA Petition,” Regulatory Focus
“The nontrivial issue of how biosimilars should be named in the US may not go away until the US Food and Drug Administration (FDA) makes a definitive decision on how these new products should be labeled and tracked.”
If you like this story, please see our blog titled “Another Perspective on 4D Bioprinting”
“Drug firms ask governments to do more in fight against superbugs,” Reuters
“More than 80 international drug and biotech firms urged governments to work with them to combat drug-resistant superbugs which could kill tens of millions of people within decades unless progress is made and new antibiotics found.”
If you like this story, please see our blog titled “You can teach an old dog new tricks: Vero cells for virus-based cancer vaccine therapies”